Trial
NCT03628391
Haloperidol for Delirium in Adult Critically Ill Patients
Phase IIITERMINATEDEFFICACY/FUTILITYConfidence: HIGH
Sponsor
Erasmus Medical Center
Collaborators
ZonMw: The Netherlands Organisation for Health Research and Development
Condition
Delirium
Intervention
Haloperidol
Why stopped
The study was stopped because of futility of being able to reach a one-day difference between treatment groups in the primary outcome of DCFD in the intended sample size.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2022-05-11